ArticleCancer research communications2023

Small-molecule PTPN2 Inhibitors Sensitize Resistant Melanoma to Anti-PD-1 Immunotherapy.

Zhouting Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.